Adocia: the annual general meeting will be held on June 28 – 05/23/2022 at 07:56


(AOF) – Adocia announces that its annual general meeting (AGM) will be held on June 28 at 10 a.m., at the Hôtel de Talleyrand, in the offices of the firm Jones Day, 2 rue Saint Florentin, in Paris. “Only shareholders who have registered their shares no later than the second business day preceding the date set for the AGM, at midnight, Paris time, will be able to physically participate in the AGM”, specifies the biotechnology company.

For shareholders holding bearer shares, their authorized intermediary must provide them with a “participation certificate”. This certificate must be attached to the remote voting or proxy form for shareholders wishing to be represented or vote by post.

The participation certificate may replace the admission card for shareholders wishing to be physically present at the Combined General Meeting.

AOF – LEARN MORE

Oncology supports laboratory performance

Oncology generated $163 billion in revenue in 2021 (out of an industry total of $613 billion), up 11.9%, according to GlobalData. Its average annual growth has reached 15.4% over the past twenty years. This segment, which is increasingly competitive, is dominated by a few heavyweights such as MSD (Merck & Co. Inc), Roche, BMS

.

L



immuno-oncology, the specialty that has been driving this market for ten years, supports research. GlobalData estimates that this segment could reach 180 billion in 2026. The major players are looking to strengthen themselves in this niche. Pfizer recently acquired Canadian biotech Trillium Therapeutics for $2.3 billion. Following this operation, the American group got hold of two promising molecules in the treatment of blood cancer.



Source link -86